SCHEMBL2780702

SCHEMBL2780702

COc1ccc(-n2c(=O)c(C(=O)O)nc3cccnc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.56
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
POLB P06746 1/20 0.50
PABPC1 P11940 1/20 0.50
ALDH1A1 P00352 8/20 0.49
CYP3A4 P08684 7/20 0.49
USP2 O75604 7/20 0.49
CYP1A2 P05177 6/20 0.49
CYP2C19 P33261 4/20 0.49
CYP2D6 P10635 2/20 0.49
MAPK1 P28482 1/20 0.49
CASP1 P29466 2/20 0.48
CASP7 P55210 2/20 0.48
CYP2C9 P11712 3/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
ALOX15 P16050 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2780593 0.86 PDE4B (0.52) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL2782278 0.85 CSF1R (0.54) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL11393864 0.84 PDE4B (0.56) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL11398304 0.83 CYP3A4 (0.69) PDE4BMEN1KMT2AALDH1A1CYP3A4
SCHEMBL11391968 0.81 PDE4B (0.54) PDE4BMEN1KMT2AALDH1A1CYP3A4
SCHEMBL30310052 0.81 ALDH1A1 (0.60) MEN1KMT2APOLBALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL28429627 0.81 ALDH1A1 (0.58) MEN1KMT2APOLBALDH1A1CYP3A4
SCHEMBL2797901 0.80 PDE4B (0.51) PDE4BMEN1KMT2AALDH1A1CYP3A4
SCHEMBL2778631 0.78 PDE4B (0.60) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL6796126 0.78 CYP3A4 (0.61) PDE4BMEN1KMT2AALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8648075-B2 Substituted pyrido[2,3-b]pyrazines and an agrochemical composition thereof KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2014-02-11 US disclosed
US-20130137577-A1 OXOPYRAZINE DERIVATIVE AND HERBICIDE IHARA CHEMICAL INDUSTRY CO., LTD. (JP) 2013-05-30 US disclosed
US-8389523-B2 Substituted quinoxaline and an agrochemical composition thereof KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2013-03-05 US disclosed
EP-2174934-B1 OXOPYRAZINE DERIVATIVE AND HERBICIDE KUMIAI CHEMICAL INDUSTRY CO (JP) 2012-06-06 EP disclosed
US-20100197674-A1 OXOPYRAZINE DERIVATIVE AND HERBICIDE KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2010-08-05 US disclosed
EP-2174934-A1 OXOPYRAZINE DERIVATIVE AND HERBICIDE KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) 2010-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137577-A1 OXOPYRAZINE DERIVATIVE AND HERBICIDE CBR3, CBR1, DDT PDE4B 3168/4885MEN1 4422/4885KMT2A 1530/4885
US-20100197674-A1 OXOPYRAZINE DERIVATIVE AND HERBICIDE CBR3, CBR1, DDT PDE4B 3168/4885MEN1 4422/4885KMT2A 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.